HOME >> BIOLOGY >> NEWS
'Smart antibiotics' may result from UCLA research

New UCLA research published in Nature may lead to an effective alternative to antibiotic drugs for treating bacterial diseases.

UCLA microbiologists report the discovery of a new class of genetic elements, similar to retroviruses, that operate in bacteria, allowing them to diversify their proteins to bind to a large variety of receptors. The team discovered this fundamental mechanism in the most abundant life?forms on Earth: bacteriophages, the viruses that infect bacteria.

"A problem with antibiotics is that bacteria can mutate and become resistant to a particular antibiotic, while the antibiotic is static and cannot change," said Jeffery F. Miller, professor and chair of microbiology, immunology and molecular genetics at UCLA, who holds UCLA's M. Philip Davis Chair in Microbiology and Immunology, and who led the research team. "Bacteriophages ("phages") are nature's anti-microbials, and they are amazingly dynamic. If the bacterium mutates in an effort to evade, the bacteriophage can change its specificity using the mechanism we discovered, to kill the newly resistant bacterium."

The use of bacteriophage to treat infections is not in itself a new idea. "Phage therapy has been practiced for nearly a hundred years in parts of the world, and even in the United States in the first half of the 20th century. But now, we think we can engineer bacteriophages to function as 'dynamic' anti-microbial agents. This could provide us with a renewable resource of smart antibiotics for treating bacterial diseases," said Miller, a member of both UCLA's David Geffen School of Medicine and the UCLA College.

"It's a bit ironic that viruses can be used to cure bacterial diseases," said Asher Hodes, a UCLA graduate student in microbiology, immunology and molecular genetics, and a member of the research team. "This approach can be effective, especially for diseases where traditional antibiotics do not work well. There is the potential for treating
'"/>

Contact: Stuart Wolpert
stuartw@college.ucla.edu
310-206-0511
University of California - Los Angeles
22-Sep-2004


Page: 1 2 3

Related biology news :

1. Smart gene therapy protects against damage from heart attack
2. Smart bomb delivery destroys tumors in mice
3. Smart bandage diagnoses danger before infection takes hold
4. Smart carriers and tiny skin-deep medicine cabinets improve drug effectiveness against cancer, AIDS, other diseases
5. New Airways Smarts Ensure That Patients Get Plenty Of Oxygen
6. Research Aims At Nations First Smart Ground Water Regulations
7. Houston minority graduation rises in sciences, engineering as result of UH-led alliance
8. Long-term heart damage may result from constant confrontation and defeat
9. Warren Pharmaceuticals publishes results of preclinical evaluation
10. U of T microbiologists achieve results with pattern recognition software
11. Loss of circadian genes results in epilepsy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2020)... ... January 21, 2020 , ... Modality ... supporting global regulatory applications, and executing global clinical trial operations. Milestone highlights ... a fastest growing company, and ISO 9001:2015 certification with the scope of ...
(Date:1/2/2020)... ... January 02, 2020 , ... ... reagents, chemicals, and medias, as well as medical grade plastic products to the ... product manufacturers. , “We are excited to bring even more advantages and ...
(Date:12/21/2019)... ... 2019 , ... The City of Tampa recently served as the host location ... these heroes. Tampa welcomed these most-highly decorated USA heroes as the National Hockey League ... distinguished service members. , The Medal of Honor, the USA military’s highest award for ...
Breaking Biology News(10 mins):
(Date:12/27/2019)... ... December 27, 2019 , ... Leak ... instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited ... . Following acquisition by CLJ Holdings in February, 2019, a comprehensive and aggressive ...
(Date:12/18/2019)... ... December 17, 2019 , ... Innovative Health, ... reprocessing Electrophysiology (EP) devices since the company’s inception in 2016. This marks a ... (a Johnson & Johnson company) have received 2 and 4 EP device clearances, ...
(Date:12/14/2019)... ... December 12, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries ... LDA LT80 (LOW TEMPERATURE -80C) helium leak testing system is designed for testing ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... and services, today announced a partnership with the Recombinant Antibody Network (RAN), a ... and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies ...
Breaking Biology Technology:
Cached News: